Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$862,569
+$24,815 QoQ
Shares Held
2,382
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,796
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jackson, Grant Investment Advisers, Inc. holds $16,628,871 across 11 Drug Manufacturers - General names. AMGN ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
30,346 | $7,636,267 | |
| 2 | JNJ |
Johnson & Johnson
|
13,554 | $3,442,309 | |
| 3 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,533 | $1,610,490 | |
| 5 | AMGN |
Amgen Inc
This page
|
2,382 | $862,569 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,529 | $203,340 | |
| 7 | PFE |
Pfizer Inc
|
6,680 | $160,854 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,035 | $130,761 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $862,569 | 2,382 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $837,754 | 2,381 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $778,997 | 2,380 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $671,353 | 2,379 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $663,961 | 2,378 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $740,554 | 2,377 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $619,280 | 2,376 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $765,248 | 2,375 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $741,756 | 2,374 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $638,582 | 2,246 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $646,892 | 2,246 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $603,634 | 2,246 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $503,541 | 2,268 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $548,289 | 2,268 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $589,889 | 2,246 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $506,248 | 2,246 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $546,451 | 2,246 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $543,127 | 2,246 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $545,552 | 2,425 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $515,676 | 2,425 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $591,093 | 2,425 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $603,364 | 2,425 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $557,556 | 2,425 | Shares | Sole | 2021-03-03 | |
| 2020-09-30 | $654,716 | 2,576 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $607,103 | 2,574 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $521,218 | 2,571 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||